The company is extremely proud of this accomplishment as it is one of the first Nutraceutical plant in North America to recieve Sauid MOH approval.
The Saudi Ministry of Health is considered by most Middle Eastern countries to have the most stringent regulations when it comes to importing pharmaceutical and nutraceutical products. Maximum LIfe will be able to use its manufactruring approval to launch its proucts in other countries throughout the Middle East with a limited importation approval process due to the fact that Maximum Life already has Saudi GMP certification.
About Maximum Life Nutraceuticals Inc.:
Maximum Life Nutraceuticals in collaboration with the Martin Clinic, has developed a line of health products called the Clinical Gold Series. Maximum Life's products, through LIMAKA international, the company's export agent, are distributed worldwide. Maximum Life throught it's commitment in bringing the highest quality products to the consumer continues to receive significant research contributions from its Scientific Advisory Board led by Dr. Anthony Martin. The company is excited by the results of these ongoing clinical studies and is currently testing another product to be launched when the clinicals are fully completed.
For more information on the company's line of products, please click here. (http://www.mln.ca/en/products.php)
About LIMAKA International:
LIMAKA (http://www.limaka.com)is committed to working in partnership with corporations and suppliers who have excellent, innovative, and unique products in the Pharmaceutical and Nutraceuticals field. LIMAKA is experienced in exporting and importing products from around the world with specialization in the Middle East.
Maximum Life Nutraceuticals Completes Saudi GMP Registration


